Publications by authors named "Jong-Ha Lim"

Claim this Profile
F
First-In-Human Dose Finding Study of Venadaparib (IDX-1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors.
Sung-Bae Kim, Kyun-Seop Bae, Jae Lyun Lee, Won Sik Lee, Chan-Young Ock, Jong-Ha Lim

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.
Myongjae Lee, In-Gyu Je, Jeong Eun Kim, Yeongran Yoo, Jong-Ha Lim

Mol Cancer Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis